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Summary
PRINCIPLES: To assess gynaecologists’ awareness of
bone healthcare in women and the prevalence of applic-
ation of national recommendations on bone healthcare in
Switzerland.
METHODS: During the annual meeting of the Swiss So-
ciety of Gynaecology and Obstetrics 2012, the Swiss As-
sociation against Osteoporosis (SVGO) performed stand-
ardised interviews with conference participants (n = 210).
Questions addressed responsibility for bone healthcare, and
whether diagnostic procedures, initiation of bone-specific
treatment and follow-up were performed in accordance
with SVGO recommendations.
RESULTS: The majority of respondents were aged 30–50
years (60%), female (70%) and working as board-certified
gynaecologists (69%). Ninety-three percent of respondents
considered care for bone health as part of the gynaeco-
logist’s expertise. As diagnostic procedures, 44% recom-
mended performing bone densitometry (DXA) only, 34%
ordered additional laboratory testing. Seventy-two percent
of respondents initiated a bone-specific treatment. Predict-
ors for not performing diagnostic procedures and not ini-
tiating a bone-specific treatment were physician’s age be-
low 30, being a trainee gynaecologist, and working at a
university clinic. Particularly, young trainee gynaecologists
working at a university clinic were especially unlikely to
initiate a bone-specific treatment (regression coefficient =
–2.68; odds ratio [OR] 0.069, 95% confidence interval [CI]
0.01–0.61; p = 0.16). Follow-ups were performed by 77%
of respondents, but were less likely to be by female physi-
cians (OR 0.27, 95% CI 0.09–0.84; p = 0.024).
CONCLUSIONS: Although the majority of board-certified
gynaecologists follow national recommendations on bone
healthcare, current medical training in obstetrics and gyn-
aecology does not sufficiently cover the subject of wo-
men’s health. However, since this is a small study our find-
ings may not reflect the findings in the total population.
Key words: bone healthcare; osteoporosis; guidelines;
gynaecology: Swiss Association against Osteoporosis
(SVGO); Switzerland
Introduction
Osteoporosis is a multidisciplinary disease. Depending on
age, comorbidities and fractures, osteoporosis treatment
falls within various fields of medical expertise, such as
general internal medicine, endocrinology, rheumatology,
orthopaedics and gynaecology. In Switzerland, bone
healthcare, including osteoporosis, is part of the educa-
tional programme to become a board-certified general in-
ternal medicine specialist, gynaecologist, rheumatologist or
endocrinologist (www.fmh.ch). Owing to menopausal oes-
trogen deficiency, women are more often affected by os-
teoporosis than men, with one in two women above the
age of 50 suffering from an osteoporotic fracture [1]. In
Switzerland, osteoporosis is in position seven of the most
frequent chronic diseases in women. However, only 17.5%
of women and 19.1% of women above the age of 65are or
have been receiving medical treatment for this condition
(Swiss Federal Statistical Office, http://www.bfs.admin.ch,
online search 02.03.2013). Thus, chances are high for wo-
men being neither diagnosed nor treated for osteoporosis,
which is reflected by increasing numbers of hospitalisa-
tions for osteoporotic fractures in women [1]. Furthermore,
women’s awareness of osteoporosis is generally low [2],
making bone healthcare an even more urgent subject to be
addressed by healthcare providers. Menopausal hormone
therapy (MHT) is one therapeutic option, especially for
primary and secondary osteoporosis prevention [3].
However, as in multiple Western countries, in Switzerland,
the most recent Swiss Health Survey (2007) by the Federal
Statistical Office reported a reduced prevalence of MHT
use by almost 50% in women aged 45 to 64 since 2002
after the publication of the Women’s Health Initiative res-
ults [4]. Thus, even more women will develop osteoporotic
fractures if the decline in bone mineral density is not dia-
gnosed in time. This future perspective is even more com-
pelling because the growing medical armamentarium
against osteoporotic fractures makes it easy to find a suit-
able medication for each individual [5]. In 2010, revised
recommendations for diagnostic procedures, bone-specific
treatment and monitoring of osteoporosis were introduced
by the Swiss Association against Osteoporosis (SVGO)
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(http://www.svgo.ch) in which the Swiss Menopause So-
ciety is represented. Recommendations are based on bone
densitometry (t-score) of the hip or spine, previous hip or
spine fractures and the World Health Organisation (WHO)
fracture risk assessment tool FRAX(R), which predicts a
patient’s 10-year probability of osteoporosis-related frac-
ture on the basis of age, gender and various risk factors [6,
7]. The aim of this study was to assess the gynaecologists’
awareness of bone healthcare in Switzerland, and the pre-
valence of the application of national recommendations in
daily practice.
Methods and materials
During the annual meeting of the Swiss Society of Gyn-
aecology and Obstetrics (SGGG) 2012 in Interlaken, the
Swiss Association against Osteoporosis (SVGO) per-
formed standardised interviews with conference parti-
cipants (n = 214; 25% of registered participants). Indi-
vidual interviews were performed by five medical students
from the University of Bern who in turn received free ac-
cess to the conference. The students were asked to per-
form about 50 interviews each. The study was approved
by persons responsible for the SGGG. Questions addressed
responsibility for bone healthcare, diagnostic procedures
according to SVGO recommendations, initiation of a bone-
specific treatment and monitoring strategy. In detail, sub-
jects were asked about their sex (female, male), age (age
<30, age 30–50, age >50), medical education (board-cer-
tified gynaecologist, trainee gynaecologist, other), work-
place (university clinic, cantonal clinic, other clinic, private
practice, other), and if they address the subject of osteo-
porosis during their consultation (yes, no). In a next step,
subjects were asked if they consider bone healthcare and
osteoporosis to be within the gynaecologist’s expertise
(yes, no). If not, they were asked who in their opinion was
the responsible physician (general practitioner, orthopaed-
ist, rheumatologist, internal medicine specialist, other). If
the answer was “yes”, they were asked if they perform
diagnostic procedures in accordance with the SVGO re-
commendations (bone densitometry [DXA] only, DXA and
laboratory analysis, none). Those who perform diagnostic
procedures were then asked if they initiate a bone-specif-
ic treatment (yes, no), and if they perform follow-up (yes,
no). Finally, those who treat women for osteoporosis were
asked about their patients’ age (age <50, age 50–59, age
60–70, age >70).
Statistical analysis was performed using SPSS 17 (SPSS
Inc. 2010). For between group comparisons the exact Fish-
er Test, and, where applicable, the chi-square test were
used. Confidence intervals as a measure of precision for re-
lative values (%) were calculated in accordance with New-
combe (“exact binomial tail areas”). Data have been in-
terpreted descriptively. Thus, p-values ≤0.05 indicate an
exploratory significant difference. Logistic regression ana-
lysis was performed for multivariate prediction of a binary
variable presenting the respective odds ratio of the predict-
or and the descriptive 95% confidence interval.
Results
Subjects’ characteristics
A total of 214 conference participants (25% of registered
participants) volunteered for the interview. For 210 sub-
jects the dataset was complete, for three participants in-
formation on their age and sex, and for one participant in-
formation on medical training and workplace was missing.
Sex was not equally distributed across age groups (female
n = 148, male n = 62), reflecting the sex distribution among
gynaecologists. Below the age of 30 (mostly trainees), 95%
of respondents were female. In the age group 30–50 years,
female respondents still dominated with 76%, while above
age 50, sex distribution was almost equal (female 52%,
male 48%). The trend for subjects being more likely to
be female with decreasing age was significant (p <0.01).
The majority of board-certified gynaecologists worked in
private practice (49%); 19% were employees at a canton-
al clinic, 17% at a university clinic, and 14% in other clin-
ics. All but two trainee gynaecologists were employees at
a hospital (university clinic [44%], cantonal clinic [37%],
other clinics [13%]). Eighty-five percent of respondents be-
low the age of 30 were trainee gynaecologists. There was
no significant correlation between medical education and
workplace (p = 0.47).
Attitude towards bone health and osteoporosis in
women’s healthcare
Independently of sex (p = 0.48), age (p = 0.29) and medical
education (p = 0.62), the majority of respondents (93%)
considered bone health and osteoporosis to be being part of
their medical expertise as a gynaecologist. However, few-
er respondents (86%) actually addressed the subject during
their consultation, again independently of sex (p = 0.25)
and age (p = 0.07). Interestingly, significantly more re-
spondents working in private practice addressed the subject
during their consultation compared with employees at a
clinic (p = 0.01), although the latter more often considered
bone healthcare to be part of their medical expertise (p =
0.01). When taking medical education into account, signi-
ficantly more board-certified gynaecologists counselled pa-
tients about osteoporosis than did trainee gynaecologists (p
= 0.01). Of those who considered bone health and osteo-
porosis not to be part of the gynaecologists’ field of expert-
ise, 4% felt the general practitioner, 3% the rheumatologist,
and 1% the internal medicine specialist to be the respons-
ible physician. None of the respondents believed that os-
teoporosis was primarily the field of orthopaedic expertise.
Diagnostic procedures, bone-specific treatment and
follow-up
Respondents who agreed to bone healthcare and osteo-
porosis being part of the gynaecologist’s expertise (n =
197) were asked if they perform diagnostic procedures in
accordance with SVGO recommendations, initiate a bone-
specific treatment and perform follow-ups, or if they leave
that to others (table 1). In general, there was a trend to per-
forming diagnostic procedures in accordance with SVGO
recommendations less often in male (p = 0.09) and younger
respondents (p = 0.06). In clinics, any kind of diagnostic
procedures were significantly less often performed than in
Original article Swiss Med Wkly. 2014;144:w13931
Swiss Medical Weekly · PDF of the online version · www.smw.ch Page 2 of 6
private practice (p <0.01). Similarly, when taking medic-
al education into account, significantly more trainee gynae-
cologists did not perform diagnostic procedures compared
with board-certified gynaecologists (p = 0.01). However, if
diagnostic procedures were performed, medical education
did not have a significant impact on the procedures chosen
(DXA only: p = 0.38; DXA plus laboratory analysis: p =
0.08). There was no sex-dependent difference in the fre-
quency of treatment initiation (p = 0.48). Similarly, work-
place did not have an impact (p = 0.56). However, board-
certified gynaecologists were significantly more likely to
initiate a bone-specific treatment than trainee gynaecolo-
gists (p <0.01). In respect to performing follow-ups, re-
spondent’s age (p = 0.34), workplace (p = 0.56), and med-
ical education (p = 0.84) did not have an impact. However,
male respondents performed follow-ups significantly more
frequently (p = 0.02). Most patients who received a bone-
specific treatment by gynaecologists were within the age
group 50–59 (36%) and 60–69 (38%), whereas only in few
patients below the age of 50 (9%), or above the age of 70
(17%) was a bone-specific treatment initiated by gynaeco-
logists.
Prediction for adequate bone healthcare
The probability of adequate bone healthcare depends on
various factors, some of which are associated with the char-
acteristics of the healthcare provider. Therefore, the pre-
dictive value of relevant factors presented above (section
“Subjects’ characteristics”) will be provided.
Significant predictive factors for the subject of osteoporos-
is being addressed during a consultation were the medical
training and workplace, but not the age of the respondent.
In detail, being a board-certified gynaecologist increased
the likelihood for the subject osteoporosis being addressed
during a consultation, whereas being a trainee gynaeco-
logist and working at a university clinic decreased the
chances (table 2).
The likelihood of performing a diagnostic procedure that
comprises bone densitometry (DXA) and laboratory ana-
lysis in accordance with SVGO recommendations was
highest in board-certified gynaecologists. However, pre-
dictive factors for not performing any diagnostic procedure
were respondent’s aged below 30, being a trainee gyn-
aecologist, working at a university clinic or other places
(table 2). Logistic regression analysis for the combination
of either two or all relevant variables (respondent’s age,
medical training and workplace) did not reveal any signi-
ficant impact on performing a diagnostic procedure. Pre-
dictive factors for initiating a bone-specific treatment were
respondent’s aged above 50, being a board-certified gynae-
cologist and working at other clinics. However, predictive
factors for not initiating a bone-specific treatment were re-
spondent’s aged below 30, being trainee gynaecologist and
working at a university clinic (table 2).
The question if there was a combined effect of age below
30, being a trainee gynaecologist and working at a uni-
versity clinic was further analysed with logistic regression
analysis. Nine out of 214 respondents fulfilled all criteria.
The combined criterion age below 30 and working at a
university clinic as well as the combined criterion being
a trainee gynaecologist and working at a university clinic
were associated with low chances of initiating a bone-spe-
cific treatment. In particular, young trainee gynaecologists
working at a university clinic were especially unlikely to
initiate a bone-specific treatment (table 3).
The likelihood of performing follow-ups was not affected
by the respondent’s age, medical education or workplace.
However, chances of performing a follow-up were signific-
antly reduced if respondents were female (table 2). Logistic
regression analysis for the combination of either two or all
relevant variables (respondent’s age, medical training and
workplace) did not reveal any significant impact on per-
forming follow-ups.
Discussion
To our knowledge, this is the first study investigating the
gynaecologists’ awareness of bone healthcare and their ap-
plication of national recommendations on screening, treat-
ment and monitoring of women at risk for osteoporosis. We
were able to show that (1.) the absolute majority of gynae-
cologists consider bone healthcare to be part of their med-
ical expertise, (2.) board-certified gynaecologists cover all
aspects of bone healthcare and apply national recommend-
ations, but (3.) physicians below the age of 30 and those
working at a university clinic all need more medical educa-
tion on bone healthcare.
In Switzerland in 2012, there were 1,493 registered board-
certified gynaecologists who predominantly worked in
private practices (69%). Sex distribution was almost equal
(female 53%, male 47%). In addition, there were 560 train-
ee gynaecologists who predominantly worked in clinics
(99%) (http://aerztestatistik.myfmh2.fmh.ch/; ht-
tp://www.fmh.ch/bildung-siwf/weiterbildung_allgemein/
aerztedemographie.html). Thus, of board-certified and
trainee gynaecologists (n = 2,053), approximately 42% at-
Table 1: Prevalence of diagnostic procedures, initiation of bone-specific treatment and follow-up performed by gynaecologists (n = 214).
Necessary tasks in bone healthcare n (%)
Diagnostic procedures (SVGO-recommendation)
Bone densitometry only
Bone densitometry and laboratory analysis
None
195
86 (44)
66 (34)
43 (22)
Initiation of bone-specific treatment
Yes
No
154
112 (73)
42 (27)
Follow-up
Yes
No
118
91 (77)
27 (23)
SVGO = Swiss Association against Osteoporosis
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tended the conference in Interlaken 2012. Of those, 25%
took part in the interview, corresponding to approximately
10% of all board-certified or trainee gynaecologists in
Switzerland. Since most respondents were board-certified
gynaecologists (69%) and above the age of 30 (90%), our
cohort represents the gynaecological outpatient care situ-
ation in Switzerland quite well.
In the specific area of osteoporosis there are several barri-
ers to optimal bone healthcare at the patient, provider and
healthcare system level [8]. Barriers at the patient level in-
clude lack of awareness and understanding of the poten-
tial morbidity and mortality of untreated osteoporosis [9].
In addition, there are multiple patient specific character-
istics that affect the likelihood of being diagnosed with
and treated for osteoporosis [10–16]. Potential barriers at
the physician level are also numerous and include lack of
awareness of the potential morbidity, mortality and health-
care costs associated with osteoporosis, lack of time and,
most importantly, uncertainty about the indications for
DXA testing and for initiation of bone-specific treatment
[9].
Physicians’ adherence to national guidelines for bone
healthcare has been investigated before. However, most
studies have been addressed the management of long-term
systemic glucocorticoids [15, 17–23], and of postmeno-
pausal women in the primary care setting by either ana-
lysing the rate of adequately screened and treated women
[10, 11, 16, 24–34], or by asking physicians about their ad-
herence to national guidelines [35–39], respectively. So far,
there has not been any study investigating the gynaecolo-
gists’ application of national guidelines, although their sig-
nificance in bone healthcare has been proven before [10,
11, 29, 30].
Previous studies have reported varying numbers for screen-
ing rates in at-risk postmenopausal women, ranging from
19%‒96% [16, 25, 26, 30, 32]. Our results are comparable
to those of a recent American study in postmenopausal
women, which showed a screening rate of 79% for gyn-
aecologists that was significantly higher than for general
internists [30]. The initiation of a bone-specific treatment
also varied tremendously, ranging from approximately
30%–93% [10, 11, 16, 25, 28, 29, 32, 33], with non-bone
specialists being as ”aggressive“ in their choice of medic-
ation as bone specialists in at least one study [31]. Inform-
ation on the frequency of follow-ups has been rarely re-
ported and was low in one study (13%) [32]. According
to our study, board-certified gynaecologists in Switzerland
have a high adherence to SVGO recommendations, reach-
ing almost 75% for each task. Unfortunately, this is not true
for trainee gynaecologists. In addition, there seems to be a
mismatch between most gynaecologists’ point of view that
bone healthcare is within their field of expertise and those
Table 2: Logistic regression analysis for prediction of the chance of the subject osteoporosis being addressed during a consultation, of (not) performing diagnostic
procedures in accordance with Swiss Association against Osteoporosis (SVGO) recommendations, of (not) initiating a bone-specific treatment, and of performing follow-
ups.
Odds ratio 95% confidence interval p-value
Prediction of the chance of the subject osteoporosis being
addressed during a consultation
Board-certified gynaecologist 3.08 1.39–6.78 0.005
Trainee gynaecologist 0.38 0.17–0.85 0.019
Workplace university clinic 0.31 0.14–0.69 0.005
Prediction of the chance of performing diagnostic procedures
according to SVGO-recommendations
Board-certified gynaecologist 2.17 1.08–4.34 0.029
Prediction of the chance of NOT performing diagnostic procedures
according to SVGO-recommendations
Respondent’s age below 30 years 3.78 1.45–9.83 0.006
Trainee gynaecologist 2.06 1.01–4.21 0.048
Workplace university clinic 3.61 1.78–7.34 <0.001
Other workplaces 5.35 1.55–18.48 0.008
Prediction of the chance of initiating a bone-specific treatment
Respondent’s age above 50 years 1.88 1.03–3.44 0.039
Board-certified gynaecologist 3.59 1.93–6.69 <0.001
Workplace other clinics 2.58 1.08–6.16 0.032
Prediction of the chance of NOT initiating a bone-specific treatment
Respondent’s age below 30 years 0.28 0.09–0.79 0.017
Trainee gynaecologist 0.36 0.19–0.68 0.002
Workplace university clinic 0.37 0.19–0.71 0.003
Prediction of the chance of performing follow-ups
Female 0.27 0.09–0.84 0.024
Table 3: Logistic regression analysis for prediction of the chance of initiating a bone-specific treatment combining two or three covariable.
Regression coefficient Odds ratio 95% confidence
interval
p-value
Respondent’s age below 30 AND workplace university clinic –2.68 0.069 0.01–0.61 0.016
Trainee gynaecologist AND workplace university clinic –1.39 0.25 0.09–0.71 0.010
Respondent’s age below 30 AND trainee gynaecologist AND
workplace university clinic
–2.68 0.069 0.01–0.61 0.016
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actually addressing the subject during their consultation. In
addition, independent of medical education, most gynaeco-
logists performing diagnostic procedures for osteoporosis
seem to be either unaware of laboratory analysis being part
of it or not competent enough for this diagnostic step.
As mentioned above, the likelihood of performing appro-
priate bone healthcare depends on various factors including
the physicians’ characteristics. In our study, chances were
highest in board-certified gynaecologists, and, additionally,
for prescription, also in doctors above the age of 50.
However, considering the impact of sex, we found a trend
for male gynaecologists to perform diagnostic procedures
less often and for female care providers to perform follow-
ups less often. This partly contrasts with previous studies
showing that female doctors more often knew osteoporosis
guidelines [35], whereas patients seen by male physicians
were less likely to have care that was adherent with
guidelines [25]. This slight discrepancy may result from the
association between age and sex in our study, with a sig-
nificant trend for subjects being more likely to be female
with decreasing age.
Experience in bone healthcare might be less broad in
younger doctors. This is especially true for trainee gynae-
cologists. In Switzerland, to become a board-certified gyn-
aecologist, trainee gynaecologists are obliged to work in
clinics with differing levels of specialisation, thus provid-
ing a broad medical experience and expertise. However,
there are several possible explanations as to why the like-
lihood of not performing diagnostic procedures and initiat-
ing a bone-specific treatment was increased in trainee gyn-
aecologists, and respondents below the age of 30. Most
trainee gynaecologists are not much involved in outpatient
care dealing with aspects of menopausal transition such as
bone healthcare, and osteoporosis. The focus of medical
training lies on obstetrics and gynaecological surgery.
Therefore, for most (trainee) gynaecologists the organ bone
is not as familiar as, for example, the uterus or the mam-
mary gland. As a consequence, gynaecologists working in
private practice have to acquire their knowledge on bone
healthcare quite late, possibly even after board certifica-
tion. However, as we could demonstrate, they do succeed.
Furthermore, as a result of increasing specialisation within
the field of gynaecology and obstetrics, obtaining the board
certificate within the shortest time period possible and ac-
quiring broad experience in all sub-domains at the same
time is almost impossible. This might also be the reason
why bone healthcare was less frequently offered by all
physicians at university clinics. Since all university clinics
provide a section on gynaecological endocrinology and re-
productive medicine, most patients will be transferred to
the respective colleague within the clinic.
Our study has some limitations. As interviews were per-
formed at a conference during the breaks, some conference
participants might have attended other exclusive meetings
that did not allow for socialising. Thus only 25% of par-
ticipants could be recruited for interviews. According to
the interview design some respondents might not have
answered the questions addressing treatment initiation and
monitoring, if the answer to the question about performing
diagnostic procedures was already negative. Thus, the co-
hort size of respondents became smaller from one question
to another. Furthermore, the medical students performing
the interviews might have preferentially addressed confer-
ence attendees they considered to be more approachable.
However, as they performed interviews during a whole day
initial reserve would have disappeared with time. Finally,
we only captured the gynaecologists’ perspective and were
not able to compare their self-concept with actual numbers
from patient records.
Although differences in international healthcare systems do
exist, our findings emphasise the role of gynaecologists
not only for specialised, but also for primary healthcare
in women. Since various multifaceted interventions target-
ing high-risk patients and their primary care providers have
only resulted into modest improvement in bone healthcare,
it may be worthwhile to develop and evaluate more in-
tensive multidisciplinary interventions that target various
health professionals including gynaecologists [8]. Further-
more, with the introduction of Swiss Diagnosis Related
Groups (SwissDRG) for inpatient care in 2012, clinics will
be forced to improve their efficiency. This will lead to an
increased administrative burden, especially for trainee gyn-
aecologists, and a redistribution of cases and human re-
sources depending on cost efficiencies. In order to avoid
the internationally existing osteoporosis treatment care
gap, it is mandatory to develop a multidisciplinary ap-
proach to make certain of appropriate bone healthcare in at-
risk patients.
Conclusion
Bone healthcare is part of the gynaecologists’ expertise.
Our study suggests that the current training in the field
of obstetrics and gynaecology does not sufficiently cover
training in women’s health, including bone healthcare, by
far the most important cohort of women consulting in
private practice. Despite the expected increasing financial
pressures within the Swiss healthcare system, education
covering all aspects of bone healthcare needs to be im-
proved. However, since this is a small study our findings
may not reflect the findings in the total population.
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